Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,893 | 22,055 | 29,784 | 31,735 | 40,577 |
| TOTAL | $16,272 | $23,019 | $31,063 | $33,905 | $43,025 |
| Non-Current Assets | |||||
| PPE Net | 1,051 | 1,122 | 1,159 | 1,276 | 1,404 |
| Other Non-Current Assets | 18,785 | 19,568 | 20,351 | 21,135 | 21,917 |
| TOTAL | $19,836 | $20,690 | $21,510 | $22,411 | $23,321 |
| Total Assets | $36,108 | $43,709 | $52,573 | $56,316 | $66,346 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 663 | 627 | 680 | 725 | 1,179 |
| Accrued Expenses | 775 | 1,103 | 2,413 | 2,247 | 2,586 |
| Other current liabilities | 3,266 | 3,059 | 3,486 | 4,039 | 4,347 |
| TOTAL | $9,522 | $9,480 | $11,163 | $11,470 | $12,631 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 7 | 32 | 216 | 398 |
| Other Non-Current Liabilities | 25,441 | 26,695 | 27,926 | 29,113 | 30,259 |
| TOTAL | $37,303 | $38,557 | $39,788 | $40,974 | $42,121 |
| Total Liabilities | $46,825 | $48,037 | $50,951 | $52,444 | $54,752 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,775 | 1,775 | 1,644 | 1,325 | 1,318 |
| Common Shares | 2 | 2 | 2 | 66 | 1 |
| Retained earnings | -433,709 | -426,758 | -420,774 | -413,337 | -404,790 |
| TOTAL | $-10,717 | $-4,328 | $1,622 | $3,872 | $11,594 |
| Total Liabilities And Equity | $36,108 | $43,709 | $52,573 | $56,316 | $66,346 |